Long-Acting Octreotide for the Treatment of Congenital Hyperinsulinism

Dr. Khalid Hussain, a leading pediatric endocrinologist specializing in congenital hyperinsulinism (HI) presented information on the use of long-acting octreotide as a medical therapy for patients with HI at the Congenital Hyperinsulinism International Endocrine Society Meeting in Berkeley, California on June 15, 2013. Dr. Hussain presented information on published studies and on an ongoing study … Read more

Share

NORD Interim Report on Exendin (9-39) is in

The first interim report on the NORD Research Grant to Dr. Diva DeLeon of the Children’s Hospital of Philadelphia for her work on exendin (9-39) has been submitted.  NORD has graciously permitted us to share the public portion of this interim report.  This groundbreaking research is funded by the Mario Batali Foundation.  Dr. Deleon receives … Read more

Share

Scholarships Available for Milan Meeting

Congenital Hyperinsulinism International is thrilled to announce family scholarship grants for the upcoming CHI Family Conference in Milan on September 17 and 18, 2013.  The Family Scholarships will cover the cost of registration for two family members and one night at the conference hotel, the NH Milano 2 Hotel.  This generous donation was provided by … Read more

Share